Bank Hapoalim Bm Orgenesis Inc. Transaction History

Bank Hapoalim Bm

  • $660 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022
BUY
$2.61 - $4.9 $83,655 - $157,054
32,052 New
32,052 $92,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Bank Hapoalim Bm Portfolio

Follow Bank Hapoalim Bm and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email